Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

NUS and Harvard Scientists Develop Novel Drug to Treat Liver Cancer Effectively

A team of Scientists from the Cancer Science Institute of Singapore CSI Singapore at the National University of Singapore NUS developed a novel peptide drug called FFW to treat liver cancer effectively FFW could potentially stop the development of Hepatocellular Carcinoma HCC or primary liver can..

Pfizer Launches Janus Kinase 3 (JAK3) Inhibitor PF-06651600

Pfizer launched its investigational oral Janus Kinase 3 JAK3 inhibitor PF06651600 which is used for the treatment of patients with alopecia areata Alopecia areata is chronic autoimmune skin disease in which immune cells attack healthy hair follicles causing hair loss in round patches and causes h..

Alnylam’s ONPATTRO to Treat Patients with Hereditary ATTR Amyloidosis in Adults

Alnylams ONPATTRO patisiran lipid complex injection is a firstofitskind RNA interference RNAi therapeutic used to treat the polyneuropathy of hereditary transthyretinmediated hATTR Amyloidosis in adults RNAi is a completely new approach to the treatment of these diseases targeting the faulty prot..

Encorafenib (BRAFTOVI™) to Treat Patients with BRAFV600E-Mutant Metastatic Colorectal Cancer (mCRC)

Encorafenib BRAFTOVI in combination with binimetinib MEKTOVI and cetuximab has been designed to treat patients with BRAFV600Emutant metastatic colorectal cancer mCRC BRAFV600Emutant mCRC will be an important treatment option to the cancer patients in critical need The results were made from th..

Daiichi Sankyo’s FLT3 Inhibitor Quizartinib Treats Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company Limited announced quizartinib an investigational FLT3 inhibitor for the treatment of adult patients with relapsedrefractory FLT3ITD Acute Myeloid Leukemia AML Quizartinib is the first FLT3 inhibitor to enhance overall survival as an oral single agent compared to chemotherap..

Portola Pharmaceuticals Introduces Antidote for the Reversal of Factor Xa Inhibitors

Portola Pharmaceuticals develops Andexxa coagulation factor Xa recombinant inactivatedzhzo the first and only antidote indicated for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to lifethreatening or uncontrolled bleeding Andexxas rapid reversal of..

Amgen and Novartis Pharma Collaborate to Develop Novel Approach for Migraine Prevention

Amgen in collaboration with Novartis Pharma AG has developed Aimovig a novel therapeutic approach to prevent a migraine by blocking the calcitonin generelated peptide receptor CGRPR which is believed to play a critical role in a migraine Aimovig 70 mg is selfadministered once monthly via Amgen39s..

World's First Metal-based Probes for Detection of Dopamine Receptors - Developed by HKBU Researchers

A team of researchers of Hong Kong Baptist University has developed the worlds first metalbased probes for the identification of dopamine receptors in living cells This breakthrough innovation helped the researchers to understand the dopamine receptors in carcinogenesis Dopamine is an organic che..

ChargePoint Technology launches VERIFI®- a Intelligent Monitoring Hub

ChargePoint Technology launches firstofitskind intelligent monitoring platform namely VERIFI which helps in tracking the most critical data of numerous valve installations This will send alerts directly to HS maintenance and compliance teams to reduce unplanned maintenance downtime The VERIFI com..

First-of-its-kind Doptelet will soon be Available to Control Life-threatening Bleeding

Dova Pharmaceuticals announced that US Food and Drug Administration FDA has given green signal to Doptelet avatrombopag prescriptive medicine for the treatment of thrombocytopenia in adult patients affecting with a chronic liver disease Doptelet is used to treat low platelet counts in adults affe..